AKT1 and breast carcinoma: Subsequently, Zhu et al. found that compound 1 causes apoptosis in adriamycin-resistant human breast cancer cells both in vitro and vivo, and it exerts these antitumor effects through multiple mechanisms mainly involving the suppression of Akt signaling [42].